首页> 外文期刊>Journal of applied microbiology >Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility.
【24h】

Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility.

机译:重复的治疗剂量选择了对大环内酯类耐药的弯曲杆菌属。在土耳其的设施中。

获取原文
获取原文并翻译 | 示例
       

摘要

Aims. This study assessed the effects of the therapeutic use of TylanReg. in a large-scale turkey production facility on the selection of macrolide-resistant Campylobacter. Methods and Results. A flock of production turkeys (c. 30 000 birds) was followed from brooding to slaughter, and the effects of macrolide application was assessed in one half of the flock from finishing stage to final product and compared against the control barn where no macrolide was used. Overall, Campylobacter prevalence in turkeys was almost 100% by 4 weeks of age. When Campylobacter prevalence was assessed in relation to treatment, high levels of macrolide resistance were evident in this group following treatment, with Campylobacter coli becoming the dominant strain type. Over time, and in the absence of a selection agent, the population of resistant strains decreased suggesting that there was a fitness cost associated with macrolide resistance carriage and persistence. Macrolide resistance was detected in the control barn at a very low level (four isolates recovered during the study), suggesting that the creation or selection of macrolide-resistant Campylobacter was correlated with the treatment regime used. Molecular analysis of a selection of macrolide-resistant Campylobacter recovered was assessed using PCR, RFLP and sequence analysis of the 23S rRNA. The majority of isolates displaying high-level macrolide resistance (>256 mug ml-1) possessed an A2075G transition mutation in the 23S rRNA and the CmeABC efflux pump. Conclusions. These studies suggest that macrolide resistance can be promoted through the application of treatment during the grow-out phase and once established in a production facility has the potential to persist and be transferred to final product. Significance and Impact of the Study. The study highlights the prudent use of antimicrobials in treatment of disease in poultry. Of significance is the presence of macrolide-resistant Campylobacter in poultry production and finished product as a consequence of macrolide usage
机译:目的这项研究评估了TylanReg的治疗用途的效果。在大型火鸡生产设施中选择耐大环内酯弯曲菌。方法和结果。从育雏到屠宰,跟踪一群生产火鸡(约3万只鸡),并在从育肥阶段到最终产品的一半鸡群中评估施用大环内酯的效果,并与未使用大环内酯的对照谷仓进行比较。总体而言,到4周龄时,火鸡弯曲杆菌的患病率几乎达到100%。当评估与治疗有关的弯曲杆菌的患病率时,在治疗后该组中大环内酯类药物的耐药性明显升高,弯曲杆菌成为主要菌株。随着时间的流逝,在没有选择剂的情况下,耐药菌株的数量下降,这表明与大环内酯类药物的抗性和持久性相关的适应性成本。在控制仓中检测到大环内酯类药物的耐药性很低(在研究期间回收了四个分离株),这表明耐大环内酯类弯曲杆菌的产生或选择与所使用的治疗方案相关。使用PCR,RFLP和23S rRNA的序列分析评估了所选择的对大环内酯类耐药弯曲杆菌的分子分析。表现出高水平大环内酯类耐药性(> 256毫升/ ml-1)的大多数分离株在23S rRNA和CmeABC外排泵中具有A2075G过渡突变。结论。这些研究表明,可以通过在成长期中进行处理来提高对大环内酯类药物的抗药性,一旦在生产设施中建立大环内酯类药物,就有可能持续存在并转移到最终产品中。研究的意义和影响。该研究强调了在禽类疾病治疗中谨慎使用抗菌药物。重要的是使用大环内酯后在家禽生产和成品中存在抗大环内酯弯曲菌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号